Multiple myeloma--an update on diagnosis and treatment.

Abstract

Multiple myeloma is a plasma cell (PC) malignancy characterized by the accumulation of monoclonal PCs in the bone marrow and the production of large amounts of a monoclonal immunoglobulin or paraprotein. In the past years, new approaches in the diagnosis and treatment were introduced aiming to identify high-risk patients who need proper anti-myeloma treatment. Intensive therapy including autologous hematopoietic stem cell transplantation and the new agents bortezomib, thalidomide, and lenalidomide have improved patients' responses. Further optimalization of the different treatment schedules in well-defined patient groups may prolong their survival. Patient stratification is currently based on patient characteristics, extent of myeloma disease, and associated cytogenetic and laboratory anomalies. More and more gene expression studies are introduced to stratify patients and to individualize therapy.

DOI: 10.1111/j.1600-0609.2008.01127.x
050100200920102011201220132014201520162017
Citations per Year

231 Citations

Semantic Scholar estimates that this publication has 231 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Caers2008MultipleMU, title={Multiple myeloma--an update on diagnosis and treatment.}, author={Jo Caers and Isabelle Vande broek and Hendrik de Raeve and Lucienne Michaux and Fabienne Trullemans and Rik Schots and Ben van Camp and Karin Vanderkerken}, journal={European journal of haematology}, year={2008}, volume={81 5}, pages={329-43} }